agilon health, inc.
AGL
$3.51
-$0.02-0.57%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 40.40% | 54.06% | 65.46% | 74.31% | 80.61% |
| Total Other Revenue | 42.18% | 75.07% | 176.95% | 213.51% | 170.58% |
| Total Revenue | 40.41% | 54.10% | 65.62% | 74.48% | 80.74% |
| Cost of Revenue | 42.60% | 63.34% | 72.90% | 81.14% | 86.52% |
| Gross Profit | -93.05% | -129.82% | -69.74% | -49.56% | -37.44% |
| SG&A Expenses | -7.44% | -5.55% | 5.74% | 22.50% | 39.09% |
| Depreciation & Amortization | 52.48% | 118.48% | 110.51% | 121.96% | 79.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.49% | 58.26% | 67.63% | 76.46% | 82.58% |
| Operating Income | -22.42% | -182.30% | -125.12% | -129.82% | -125.39% |
| Income Before Tax | -27.96% | -353.96% | -176.75% | -140.03% | -114.47% |
| Income Tax Expenses | 83.44% | -103.56% | 295.73% | 5,135.42% | -51.77% |
| Earnings from Continuing Operations | -28.18% | -346.76% | -177.42% | -143.07% | -111.52% |
| Earnings from Discontinued Operations | 85.46% | -283.24% | -716.54% | -823.00% | -364.13% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -124.15% | -99.58% | -81.75% | -61.87% | -33.44% |
| Net Income | 0.93% | -334.16% | -239.87% | -210.24% | -146.45% |
| EBIT | -22.42% | -182.30% | -125.12% | -129.82% | -125.39% |
| EBITDA | -20.19% | -188.26% | -126.52% | -134.89% | -129.78% |
| EPS Basic | 2.24% | -333.15% | -241.94% | -211.80% | -148.42% |
| Normalized Basic EPS | -22.45% | -349.86% | -178.32% | -160.14% | -138.15% |
| EPS Diluted | 2.81% | -314.71% | -235.98% | -208.81% | -153.03% |
| Normalized Diluted EPS | -22.32% | -348.23% | -177.46% | -159.33% | -138.09% |
| Average Basic Shares Outstanding | 0.50% | 0.05% | -0.62% | -0.50% | 0.44% |
| Average Diluted Shares Outstanding | -0.05% | -0.49% | -1.16% | -1.03% | -0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
